Dr. Pirouz M Daftarian is a cellular and molecular immunologist with 20-year experience in Immuno-Oncology and vaccinology. Pirouz has led and shepherded R&D operations of two vaccine biotech companies, has served as a faculty of the Miller School of Medicine, acted as DOD and NIH intramural reviewer for vaccine and immune-oncology (IO) proposals, and is the principal inventor of several vaccine and IO related regular patents. He has authored more than 50 research papers in peer reviewed scientific journals and is an invited speaker to many vaccine and IO conferences. Pirouz has completed his PhD in the University of Ottawa, a postdoctoral fellowship on cancer biology and vaccines in the City of Hope National Medical Center, and has served in academia (University of Dalhousie and Miller School of Medicine University of Miami) and industry (NGM Biopharmaceutical, Immunovaccine, Nanovax). Dr. Daftarian is currently working as an Application Manager in MBL International leading a team of scientists to develop modern research tools and biomarkers for the development of immunetherapeutics and vaccines.